Effect of delayed treatment with sodium polystyrene sulfonate on serum lithium concentrations in mice. 1995

J G Linakis, and K M Hull, and C M Lee, and T J Maher, and W J Lewander, and P G Lacouture
Department of Pediatrics, Rhode Island Hospital, Providence, USA.

OBJECTIVE To determine the efficacy of sodium polystyrene sulfonate (SPS) in lowering serum lithium (Li) concentrations. Specifically, to determine the effects of both different doses of SPS and different times to treatment with SPS on serum Li levels. METHODS The study was a controlled, single-dose murine trial of SPS on serum Li levels. Male CD-1 mice (n = 525) were given orogastric LiCl and then divided into three main treatment groups: group SPS received a single orogastric administration of SPS in a dose of 5 gm/kg body weight at either 0, 15, 30, 45, or 90 minutes after LiCl; group half-SPS received a single orogastric administration of SPS in a dose of 2.5 gm/kg body weight at times equivalent to those of group SPS; and the control group received orogastric deionized water in a volume equivalent to that of group SPS at 0, 15, 30, 45, or 90 minutes after LiCl. Subgroups of seven to ten mice in each of the four treatment groups were sacrificed at one, two, four, and eight hours after administration of LiCl, and their blood was analyzed for Li concentration. RESULTS 1) Single doses of SPS significantly lowered serum Li concentrations; 2) this effect was dose-related; 3) the delays in administration of SPS used in this study did not significantly reduce its ability to lower serum Li concentrations; and 4) even when administered after peak serum Li concentrations had been achieved, a single dose of SPS was effective in lowering serum Li levels. CONCLUSIONS SPS may be efficacious in the treatment for Li toxicity under certain circumstances, even when there is delay to treatment. Additional study is warranted to further characterize the ability of SPS to alter Li kinetics.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D011041 Poisoning A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent. Poisonings
D011137 Polystyrenes Polymerized forms of styrene used as a biocompatible material, especially in dentistry. They are thermoplastic and are used as insulators, for injection molding and casting, as sheets, plates, rods, rigid forms and beads. Polystyrol,Polystyrene,Polystyrols
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002411 Cation Exchange Resins High molecular weight insoluble polymers which contain functional anionic groups that are capable of undergoing exchange reactions with cations. Cation Exchange Resin,Cation Exchangers (Resins),Exchange Resin, Cation,Exchange Resins, Cation,Resin, Cation Exchange,Resins, Cation Exchange
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

J G Linakis, and K M Hull, and C M Lee, and T J Maher, and W J Lewander, and P G Lacouture
November 1992, Annals of emergency medicine,
J G Linakis, and K M Hull, and C M Lee, and T J Maher, and W J Lewander, and P G Lacouture
January 1998, Journal of toxicology. Clinical toxicology,
J G Linakis, and K M Hull, and C M Lee, and T J Maher, and W J Lewander, and P G Lacouture
October 2001, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine,
J G Linakis, and K M Hull, and C M Lee, and T J Maher, and W J Lewander, and P G Lacouture
May 2018, Kidney international,
J G Linakis, and K M Hull, and C M Lee, and T J Maher, and W J Lewander, and P G Lacouture
December 1993, Annals of emergency medicine,
J G Linakis, and K M Hull, and C M Lee, and T J Maher, and W J Lewander, and P G Lacouture
January 2010, Clinical toxicology (Philadelphia, Pa.),
J G Linakis, and K M Hull, and C M Lee, and T J Maher, and W J Lewander, and P G Lacouture
November 1992, Annals of emergency medicine,
J G Linakis, and K M Hull, and C M Lee, and T J Maher, and W J Lewander, and P G Lacouture
November 2016, Pediatric nephrology (Berlin, Germany),
J G Linakis, and K M Hull, and C M Lee, and T J Maher, and W J Lewander, and P G Lacouture
January 1998, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis,
J G Linakis, and K M Hull, and C M Lee, and T J Maher, and W J Lewander, and P G Lacouture
January 1992, Pharmacology & toxicology,
Copied contents to your clipboard!